Old Web
English
Sign In
Acemap
>
Paper
>
PS01.11 Nivolumab Versus Placebo in Relapsed Malignant Mesothelioma: The CONFIRM Phase 3 Trial
PS01.11 Nivolumab Versus Placebo in Relapsed Malignant Mesothelioma: The CONFIRM Phase 3 Trial
2021
D Fennell
Christian H Ottensmeier
Raffaele Califano
Gerard G. Hanna
S Ewings
K. Hill
S. Wilding
Sarah Danson
M Nye
Nicola Steele
L. Johnson
Joanne Lord
C. Middleton
E. Marwood
Peter W. Szlosarek
S. Chan
A. Gaba
Liz Darlison
P. Wells-Jordan
C. Richards
C. Poile
Jason F. Lester
Keywords:
Internal medicine
Medicine
Nivolumab
Oncology
Placebo
relapsed malignant mesothelioma
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
14
Citations
NaN
KQI
[]